Background There is no consensus regarding the optimal time to initiate adjuvant
chemotherapy after surgery for stage III colon cancer, and the relevant postoperative …

Background Currently available data suggest that delaying the start of adjuvant
chemotherapy in colon cancer patients has a detrimental effect on survival. We analysed …

BACKGROUND. An important advance in medical oncology has been the use of adjuvant
chemotherapy for lymph node‐positive colon cancer. However, to the authors' knowledge …

Background Adjuvant chemotherapy after resection is the standard of care for stage III colon
cancer, yet many patients omit chemotherapy. We aimed to describe the impact of delayed …

BACKGROUND: Several reports suggest that the efficacy of adjuvant chemotherapy on
survival diminishes over time for colon cancer; however, precise timing of its loss of benefit …

BACKGROUND: Clinical trials commonly mandate that adjuvant chemotherapy for colon
cancer should commence within 8 weeks (56 days) of surgery. OBJECTIVE: We investigated …

Background and Objectives In stage III colonic cancer, time from surgery to start of adjuvant
chemotherapy may influence survival. In this study, we evaluated the effect of timing of …

Purpose To evaluate factors affecting the use and delay≥ 8 weeks of adjuvant
chemotherapy and the impact of chemotherapy use and delay on survival. Methods …

BACKGROUND: It is unclear whether delays in commencing adjuvant chemotherapy after
surgical resection of colon adenocarcinoma adversely impact survival. METHODS: Patients …

Background Postoperative adjuvant chemotherapy (AC) is now well-accepted as standard
for high-risk stage II and stage III colorectal cancer (CRC) patients, however the optimal time …